OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer

Virginie Baylot(Centre National de la Recherche Scientifique), Palma Rocchi(Centre National de la Recherche Scientifique)

Cell Death and Disease

October 20, 2011

10.1038/cddis.2011.104

Cited by 100

Related Papers

Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

|Oncotarget|2017|11

Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer

|Pharmaceutics|2021|11

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment

|Biomedicines|2021|11